Skip to main content

Table 3 Estimates of 6-month survival without distant brain failure based on a new nomogram[80]

From: Stereotactic radiosurgery (SRS) for brain metastases: a systematic review

Primary tumor type 1-3 BM, stable systemic disease 1-3 BM, progressive systemic disease 4-13 BM, stable systemic disease 4-13 BM, progressive systemic disease
Renal cell cancer 69% 67% 48% 46%
Malignant melanoma 57% 55% 32% 30%
Lung, adeno ca 74% 72% 55% 53%
Lung, squamous ca 58% 57% 33% 32%
Breast, Her-2 positive 73% 72% 53% 52%
Breast, Her-2 negative 67% 66% 43% 42%
  1. Sex, age and race impact slightly on failure risk. The examples refer to approximately 55-60 years-old Caucasian females. The differences for male patients are in the order of 1-2%.
  2. BM: brain metastases.